Published in Eur J Neurosci on October 01, 2001
Narcolepsy Protect Against Alzheimer's Disease? (PROTECMAN) | NCT03378453
Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science (2009) 4.92
Afferents to the orexin neurons of the rat brain. J Comp Neurol (2006) 2.57
Sleep homeostasis and cortical synchronization: II. A local field potential study of sleep slow waves in the rat. Sleep (2007) 1.67
Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice. PLoS One (2011) 1.66
Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol (2011) 1.53
Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons. J Clin Invest (2007) 1.45
The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol (2014) 1.42
Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake. J Neurosci (2007) 1.40
Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy. J Physiol (2007) 1.30
Running promotes wakefulness and increases cataplexy in orexin knockout mice. Sleep (2007) 1.26
Multiple roles for orexin/hypocretin in addiction. Prog Brain Res (2012) 1.26
Clinical and neurobiological aspects of narcolepsy. Sleep Med (2007) 1.26
Centrally administered orexin A increases motivation for sweet pellets in rats. Psychopharmacology (Berl) (2005) 1.23
Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect. J Neurophysiol (2006) 1.22
The diurnal rhythm of hypocretin in young and old F344 rats. Sleep (2004) 1.22
Sleep related changes in blood pressure in hypocretin-deficient narcoleptic mice. Sleep (2011) 1.13
Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle. J Physiol (2010) 1.12
Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice. Proc Natl Acad Sci U S A (2011) 1.09
The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats. Neuroscience (2007) 1.09
Optogenetic manipulation of activity and temporally controlled cell-specific ablation reveal a role for MCH neurons in sleep/wake regulation. J Neurosci (2014) 1.09
Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences. J Neurosci (2010) 1.07
Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor. Br J Pharmacol (2009) 1.07
Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone. PLoS One (2012) 1.06
Multi-transcriptional profiling of melanin-concentrating hormone and orexin-containing neurons. Cell Mol Neurobiol (2005) 1.05
Central chemoreceptors: locations and functions. Compr Physiol (2012) 1.04
Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness. Sleep (2008) 1.04
Hypocretin/orexin in arousal and stress. Brain Res (2009) 1.03
Central chemoreception in wakefulness and sleep: evidence for a distributed network and a role for orexin. J Appl Physiol (1985) (2010) 1.02
Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice. Eur J Neurosci (2008) 1.01
Circadian preference modulates the neural substrate of conflict processing across the day. PLoS One (2012) 0.98
Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists. PLoS One (2011) 0.98
Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity. Brain Res (2008) 0.97
The orexin receptor 1 (OX1R) in the rostral medullary raphe contributes to the hypercapnic chemoreflex in wakefulness, during the active period of the diurnal cycle. Respir Physiol Neurobiol (2009) 0.97
Circadian and dark-pulse activation of orexin/hypocretin neurons. Mol Brain (2008) 0.96
Effects of hypocretin2-saporin and antidopamine-beta-hydroxylase-saporin neurotoxic lesions of the dorsolateral pons on sleep and muscle tone. Eur J Neurosci (2004) 0.94
CSF histamine levels in rats reflect the central histamine neurotransmission. Neurosci Lett (2007) 0.91
Hypocretin/Orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis. Curr Neuropharmacol (2009) 0.90
Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol Biochem Behav (2010) 0.89
Neurotensin co-expressed in orexin-producing neurons in the lateral hypothalamus plays an important role in regulation of sleep/wakefulness states. PLoS One (2013) 0.89
Technologies of sleep research. Cell Mol Life Sci (2007) 0.87
Orexin neurons are necessary for the circadian control of REM sleep. Sleep (2009) 0.87
Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys. J Physiol (2004) 0.85
Controlled cortical impact traumatic brain injury acutely disrupts wakefulness and extracellular orexin dynamics as determined by intracerebral microdialysis in mice. J Neurotrauma (2012) 0.85
Schizophrenia, hypocretin (orexin), and the thalamocortical activating system. Schizophr Bull (2007) 0.85
Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol (2015) 0.84
Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice. Sleep (2013) 0.84
Narcolepsy and orexins: an example of progress in sleep research. Front Neurol (2011) 0.83
A Path to Sleep Is through the Eye(1,2,3). eNeuro (2015) 0.83
Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators. Front Neurosci (2013) 0.82
State-dependent central chemoreception: a role of orexin. Respir Physiol Neurobiol (2010) 0.82
Orexin a suppresses gonadotropin-releasing hormone (GnRH) neuron activity in the mouse. Endocrinology (2012) 0.81
Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev (2014) 0.81
Wen-dan decoction improves negative emotions in sleep-deprived rats by regulating orexin-a and leptin expression. Evid Based Complement Alternat Med (2014) 0.81
Experience-dependent plasticity in hypocretin/orexin neurones: re-setting arousal threshold. Acta Physiol (Oxf) (2009) 0.80
Effects of rapid eye movement sleep deprivation on hypocretin neurons in the hypothalamus of a rat model of depression. Neuropeptides (2007) 0.80
Modafinil and γ-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep. Behav Pharmacol (2009) 0.80
Region-Specific Dissociation between Cortical Noradrenaline Levels and the Sleep/Wake Cycle. Sleep (2016) 0.80
Orexin modulates brown adipose tissue thermogenesis. Biomol Concepts (2012) 0.79
Energy expenditure: role of orexin. Vitam Horm (2012) 0.79
Time- and behavioral state-dependent changes in posterior hypothalamic GABAA receptors contribute to the regulation of sleep. PLoS One (2014) 0.78
Hypocretin/orexin involvement in reward and reinforcement. Vitam Horm (2012) 0.77
Neurobiology and sleep disorders in cluster headache. J Headache Pain (2015) 0.77
Locus Coeruleus Neural Fatigue: A Potential Mechanism for Cognitive Impairment during Sleep Deprivation. Sleep (2016) 0.77
Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling. Proc Natl Acad Sci U S A (2016) 0.77
An orexinergic projection from perifornical hypothalamus to raphe pallidus increases rat brown adipose tissue thermogenesis. Adipocyte (2012) 0.77
Reducing Adsorption To Improve Recovery and in Vivo Detection of Neuropeptides by Microdialysis with LC-MS. Anal Chem (2015) 0.76
Orexin-1 receptor mediates the increased food and water intake induced by intracerebroventricular injection of the stable somatostatin pan-agonist, ODT8-SST in rats. Neurosci Lett (2014) 0.76
Diurnal inhibition of NMDA-EPSCs at rat hippocampal mossy fibre synapses through orexin-2 receptors. J Physiol (2014) 0.75
Interactions of Circadian Rhythmicity, Stress and Orexigenic Neuropeptide Systems: Implications for Food Intake Control. Front Neurosci (2017) 0.75
Detection of orexin A neuropeptide in biological fluids using a zinc oxide field effect transistor. ACS Chem Neurosci (2013) 0.75
Sexually Dimorphic Changes of Hypocretin (Orexin) in Depression. EBioMedicine (2017) 0.75
Diurnal fluctuation in the number of hypocretin/orexin and histamine producing: Implication for understanding and treating neuronal loss. PLoS One (2017) 0.75
Orexin-A Suppresses Signal Transmission to Dopaminergic Amacrine Cells From Outer and Inner Retinal Photoreceptors. Invest Ophthalmol Vis Sci (2017) 0.75
Rhythms in the endocrine system of fish: a review. J Comp Physiol B (2017) 0.75
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol (2000) 9.85
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J (1990) 9.17
The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell (1999) 7.99
Hypocretin (orexin) deficiency in human narcolepsy. Lancet (2000) 7.92
Role of CBP/P300 in nuclear receptor signalling. Nature (1996) 7.36
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med (2000) 7.05
Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc (1996) 4.33
Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem (1998) 3.78
High guanine plus cytosine content in the third letter of codons of an extreme thermophile. DNA sequence of the isopropylmalate dehydrogenase of Thermus thermophilus. J Biol Chem (1984) 3.76
Kleine-Levin syndrome: a systematic review of 186 cases in the literature. Brain (2005) 3.37
CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc Natl Acad Sci U S A (1998) 3.22
Familial patterns of narcolepsy. Lancet (1989) 3.07
[Ischemic cerebral symptoms after subarachnoid hemorrhage due to aneurysmal rupture (author's transl)]. No Shinkei Geka (1978) 3.06
Colorectal tumours and pit pattern. J Clin Pathol (1994) 3.01
DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharmacol (1998) 2.93
Dopaminergic role in stimulant-induced wakefulness. J Neurosci (2001) 2.91
Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol (1996) 2.84
On the mechanism of activation of muscarinic K+ channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins. Pflugers Arch (1986) 2.81
Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol (1998) 2.62
BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat Genet (1998) 2.55
Sarin poisoning in Matsumoto, Japan. Lancet (1995) 2.52
Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol (2001) 2.47
Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J Biol Chem (1988) 2.45
Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol Cell Biol (1990) 2.41
Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med (2001) 2.41
Reconstruction of the entire upper eyelid area with a subcutaneous pedicle flap based on the orbicularis oculi muscle. Plast Reconstr Surg (1991) 2.40
Yeast manno-protein biosynthesis: solubilization and selective assay of four mannosyltransferases. Proc Natl Acad Sci U S A (1975) 2.34
Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology (2005) 2.33
Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology (2001) 2.30
A CLOCK polymorphism associated with human diurnal preference. Sleep (1998) 2.24
A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest (1997) 2.23
Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis. Eur Respir J (2007) 2.23
Structure of the linkage region between the polysaccharide and protein parts of Saccharomyces cerevisiae mannan. J Biol Chem (1974) 2.15
A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med (1997) 2.09
DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet (1992) 2.08
Coudability hairs: a revisited sign of alopecia areata assessed by trichoscopy. Clin Exp Dermatol (2009) 2.08
Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA (2001) 2.05
Characterization of the carbohydrate fragments obtained from Saccharomyces cerevisiae mannan by alkaline degradation. J Biol Chem (1974) 2.05
Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem (1996) 2.04
Mutation rate varies among alleles at a microsatellite locus: phylogenetic evidence. Proc Natl Acad Sci U S A (1996) 1.96
Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc Natl Acad Sci U S A (1996) 1.95
Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet (2000) 1.92
Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology (2001) 1.91
An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am J Surg Pathol (1982) 1.87
Caspase-independent cell killing by Fas-associated protein with death domain. J Cell Biol (1998) 1.87
Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil. Br J Ind Med (1979) 1.80
Endoscopic diagnosis and treatment of early colorectal cancer. World J Surg (1997) 1.77
Depressed type of colorectal cancer. Endoscopy (1995) 1.77
Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep (1999) 1.76
Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury. Neurology (2005) 1.76
Short-term desensitization of muscarinic K+ channel current in isolated atrial myocytes and possible role of GTP-binding proteins. Pflugers Arch (1987) 1.74
Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity. J Biol Chem (2000) 1.73
Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer (1982) 1.68
Pharmacokinetics of benzene and toluene. Int Arch Arbeitsmed (1974) 1.68
Internal jugular vein catheterization in infants undergoing cardiovascular surgery: an analysis of the factors influencing successful catheterization. Anesth Analg (1992) 1.66
Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe. J Clin Invest (1991) 1.65
The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol (1994) 1.63
Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep (1994) 1.62
How extensive should lymph node dissection be for cancer of the thoracic esophagus? J Thorac Cardiovasc Surg (1994) 1.61
The yeast Chs4 protein stimulates the trypsin-sensitive activity of chitin synthase 3 through an apparent protein-protein interaction. Microbiology (2000) 1.60
Gastrointestinal stromal tumors and KIT-positive mesenchymal cells in the omentum. Pathol Int (2001) 1.59
Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res (2001) 1.59
Blinking is controlled primarily by ocular surface conditions. Am J Ophthalmol (1997) 1.57
Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance. Jpn J Cancer Res (1996) 1.57
Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I. Antimicrob Agents Chemother (1992) 1.56
Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol (2001) 1.56
Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C. J Viral Hepat (2014) 1.54
Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis. Gastroenterology (2001) 1.54
Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol (1997) 1.53
Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res (1992) 1.52
An extensive transbasal approach to frontal skull-base tumors. Technical note. J Neurosurg (1991) 1.51
CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. Neurology (2003) 1.50
Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol (2000) 1.50
Interleukin-13 and tumour necrosis factor-alpha synergistically induce eotaxin production in human nasal fibroblasts. Clin Exp Allergy (2000) 1.49
The problem of de novo colorectal carcinoma. Eur J Cancer (1995) 1.49
The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem (2000) 1.49
Dermatome setting for autografts to cover INTEGRA. J Burn Care Rehabil (2002) 1.48
In situ hybridization with biotinylated tyramide amplification: detection of human papillomavirus DNA in cervical neoplastic lesions. Mod Pathol (1998) 1.48
Pulmonary and systemic arteriovenous fistulas in patients with left isomerism. Cardiol Young (1998) 1.47
Visceral leishmaniasis misdiagnosed as malignant lymphoma. Intern Med (1996) 1.47
Adaptive response in embryogenesis: I. Dose and timing of radiation for reduction of prenatal death and congenital malformation during the late period of organogenesis. Radiat Res (1998) 1.46
Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer. Br J Cancer (2008) 1.46
Modulation of the delayed rectifier K+ current by isoprenaline in bull-frog atrial myocytes. J Physiol (1989) 1.45
Comparison of endoscopic submucosal dissection with laparoscopic-assisted colorectal surgery for early-stage colorectal cancer: a retrospective analysis. Endoscopy (2012) 1.45
Role of three chitin synthase genes in the growth of Candida albicans. J Bacteriol (1996) 1.44
Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet (2001) 1.43
Linkage disequilibrium and haplotype analysis among eight novel single-nucleotide polymorphisms in the human tissue-type plasminogen activator (t-PA) gene. J Hum Genet (2001) 1.42
The inferior capsular shift operation for instability of the shoulder. Long-term results in 34 shoulders. J Bone Joint Surg Br (1999) 1.42
Continuous-sterilization system that uses photosemiconductor powders. Appl Environ Microbiol (1988) 1.41